CABOT ($CBT) is expected to release its quarterly earnings data on Monday, November 3rd after market close, per Finnhub. Analysts are expecting revenue of $970,370,125 and earnings of $1.70 per share.
You can see Quiver Quantitative's $CBT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CABOT Insider Trading Activity
CABOT insiders have traded $CBT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CBT stock by insiders over the last 6 months:
- SEAN D KEOHANE (President and CEO) has made 0 purchases and 4 sales selling 114,436 shares for an estimated $9,072,094.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CABOT Hedge Fund Activity
We have seen 163 institutional investors add shares of CABOT stock to their portfolio, and 225 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,222,399 shares (-84.6%) from their portfolio in Q2 2025, for an estimated $91,679,925
- FULLER & THALER ASSET MANAGEMENT, INC. added 978,297 shares (+82.1%) to their portfolio in Q2 2025, for an estimated $73,372,275
- AQR CAPITAL MANAGEMENT LLC added 478,702 shares (+123.0%) to their portfolio in Q2 2025, for an estimated $35,902,650
- BLACKROCK, INC. removed 285,903 shares (-4.1%) from their portfolio in Q2 2025, for an estimated $21,442,725
- NORGES BANK added 273,729 shares (+65.8%) to their portfolio in Q2 2025, for an estimated $20,529,675
- COPELAND CAPITAL MANAGEMENT, LLC removed 215,412 shares (-29.1%) from their portfolio in Q3 2025, for an estimated $16,382,082
- MORGAN STANLEY added 173,717 shares (+33.1%) to their portfolio in Q2 2025, for an estimated $13,028,775
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CABOT Price Targets
Multiple analysts have issued price targets for $CBT recently. We have seen 2 analysts offer price targets for $CBT in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $88.0 on 10/03/2025
- Joshua Spector from UBS set a target price of $82.0 on 08/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
